/newsroom/taxonomy/term/8111/all en /newsroom/channels/news/no-increased-heart-failure-incretin-based-drugs-259863 <p><strong><em>Æ»¹ûÒùÔº Newsroom</em></strong></p> <p><em>Canadian drug safety network provides reassuring evidence regarding risk of heart failure of anti-diabetes medications</em></p> <p>Incretin-based drugs, a type of medication used to treat type 2 diabetes, do not increase the risk of being hospitalized for heart failure relative to commonly used combinations of oral anti-diabetic drugs, according to a new study published in the <em>New England Journal of Medicine</em>.</p> Wed, 23 Mar 2016 14:49:58 +0000 nima.adibpour@mail.mcgill.ca 25548 at /newsroom